Skip to main content

Part of the book series: Endocrine Updates ((ENDO,volume 20))

Abstract

Optimal host defense is the resultant of the regulatory interactions between the three systems implicated in the homeostasis of the organism: the nervous, endocrine and immune systems. These three systems constitute a complex network whose behavior, in the last twenty years, has been studied by a now well established area of research: the neuroimmunomodulation. This science has experienced an explosive growth not only in basic research, but also expanding to the point that prospective clinical research could be now a reality. A crucial factor for the functioning of this network was the demonstration that the cells of nervous, endocrine and immune systems synthesize and secrete similar substances bearing the same receptors for them, reducing traditional differences between neurotransmitters, hormones and immune mediators. The fact that neurons and endocrine cells possessed similar substances was soon established, and it was later when cells of the immune system were involved. In this sense, the first contributions performed in 1980 showed that macrophages and lymphocytes were able to produce ACTH and endorphins (Blalock and Smith, 1980). Moreover, some years later, two important facts demonstrated that lymphocytes were competent to produce peptidic hormones and neuropeptides: lymphocytes possess the biochemical machinery for a regulated secretory pathway as well as the necessary proteases, as furin and other convertases to process neuropeptides (Taplits et al, 1988;Decroly et al, 1996;1997).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  • Abad C, Martinez C, Leceta J, Gomariz RP, Delgado M. Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: and experimental immunomodulatory therapy. J Immunol 2001;167:3182–89.

    PubMed  CAS  Google Scholar 

  • Berke G. The CTL kiss of death. Cell 1995;81:9–12.

    Article  PubMed  CAS  Google Scholar 

  • Blalock JE, Smith EM. Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc Natl Acad Sci USA 1980;77:5972–74.

    Article  PubMed  CAS  Google Scholar 

  • Cain BS, Meldrum DR, Harken AH, McIntyre RC. The physiologic basis for anticitokine clinical trials in the treatment of sepsis. J Am Coll Surg 1998;186:337–50.

    Article  PubMed  CAS  Google Scholar 

  • Chatterjee TK, Sharma RV, Fisher RA. Molecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of the L-type calcium channels. J Biol Chem 1996;271:33226–32.

    Google Scholar 

  • Couvineau A, Rouyer-Fessard C, Darmoul D, Maoret JJ, Carrero I, Ogier-Denis E, Laburthe M. Human intestinal VIP receptor: Cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem Biophys Res Commun 1994;200:769–76.

    Article  PubMed  CAS  Google Scholar 

  • Delcroy E, Wouters S, Di Bello C, Lazure C, Ruysschert JM, Seidah NG. Identification of the paired basic convertases implicated in HIV gp 160 processing based onin vitroassays and expression in CD4+ cell lines. J Biol Chem 1996;271:30442–50.

    Article  Google Scholar 

  • Delcroy E, Benjannet S, Savaria D, Seidah NG. Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp 160. FEBS Lett 1997;405:68–72.

    Article  Google Scholar 

  • Delgado M, De la Fuente M, Martinez C, Gomariz RP. Pituitary adenylate cyclase-activating polypeptide (PACAP27 and PACAP38) inhibits the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP. J Neuroimmunol 1995;62:137–46.

    Article  PubMed  CAS  Google Scholar 

  • Delgado M, Martinez C, Leceta J, Garrido E, Gomariz RP. Differential VIP and VIP1receptor gene expression in rat thymocyte subsets. Peptides 1996a;17:803–7.

    Article  CAS  Google Scholar 

  • Delgado M, Pozo D, Martinez C, Garrido E, Leceta J, Calvo JR, Gomariz RP. Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages. Regul Pept 1996b;62:161–66.

    Article  CAS  Google Scholar 

  • Delgado M, Martinez C, Johnson MC, Gomariz RP, Ganea D. Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-RI and VIP-R2) mRNA in murine lymphocytes. J Neuroimmunol 1996c;68:27–38.

    Article  CAS  Google Scholar 

  • Delgado M, Garrido E, De la Fuente M, Gomariz RP. Pituitary adenylate cyclase-activating polypeptide (PACAP38) stimulates rat peritoneal macrophage functions. Peptides 1996d;17:1097–105.

    Article  CAS  Google Scholar 

  • Delgado M, Garrido E, Martinez C, Leceta J, Gomariz RP. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide (PACAP27 and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis. Blood 1996e;87:5152–61.

    CAS  Google Scholar 

  • Delgado M, Munoz-Elias EJ, Kan Y, Gozes I, Fridkin M, Brenneman DE, Gomariz RP, Ganea D. Vasoactive intestinal and pituitary adenylate cyclase-activating polypeptide inhibit TNFa transcriptional activation by regulating NF-kB and CREB/c-Jun. J Biol Chem 1998;273:31427–36.

    Article  PubMed  CAS  Google Scholar 

  • Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit IL-12 transcription by regulating NFkB and Ets activation. J Biol Chem 1999;274:3193040.

    Google Scholar 

  • Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNy synthesis by T cells. J Neuroimmunol 1999a;96:167–81.

    Article  CAS  Google Scholar 

  • Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNFa production by macrophages:in vitroandin vivostudies. J Immunol 1999b;162:2358–67.

    CAS  Google Scholar 

  • Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages:in vitroandin vivostudies. J Immunol 1999c;162:1707–16.

    CAS  Google Scholar 

  • Delgado M, Martinez C, Pozo D, Calvo JR, Leceta J, Ganea D, Gomariz RP. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNFa and IL-6. J Immunol 1999d;162:1200–5.

    CAS  Google Scholar 

  • Delgado M, Leceta J, Abad C, Martinez C, Ganea D, Gomariz RP. Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. J Neuroimmunol 1999e;99:61–71.

    Article  CAS  Google Scholar 

  • Delgado M, Sun W, Leceta J, Ganea D. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression. J Immunol 1999f;163:4213–23.

    CAS  Google Scholar 

  • Delgado M, Leceta J, Gomariz RP, Ganea D. VIP and PACAP stimulate the induction of Th2 responses by upregulating B7.2 expression. J Immunol 1999g;163:3629–35.

    CAS  Google Scholar 

  • Delgado M, Gomariz RP, Martinez C, Abad C, Leceta J. Antiinflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock. Eur J Immunol 2000;30:3236–46.

    Article  PubMed  CAS  Google Scholar 

  • Delgado M, Ganea D. VIP and PACAP inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting FasL expression. J Immunol 2000a;164:1200–10.

    CAS  Google Scholar 

  • Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression. J Immunol 2000b;165:114–23.

    CAS  Google Scholar 

  • Delgado M, Abad C, Martinez C, Leceta J, Gomariz RP. Vasoactive intestinal peptide prevents experimental arthritis by down-regulating both autoimmune and inflammatory components of the disease. Nat Med 2001;7:563–68.

    Article  PubMed  CAS  Google Scholar 

  • Delgado M, Ganea D. Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAPin vitroandin vivo.J Immunol 2001a;167:966–75.

    CAS  Google Scholar 

  • Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NFkB, NF-AT, and early growth factors 2/3. J Immunol 2001b;166:1028–40.

    CAS  Google Scholar 

  • Delgado M, Ganea D. VIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4+ T cells. J Neuroimmunol 2001c;112:78–88.

    Article  CAS  Google Scholar 

  • Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit nuclar factor kappa-B-dependent gene activation at multiple levels in the human monocytic cell line THP-1. J Biol Chem 2001d;276:369–380.

    Article  CAS  Google Scholar 

  • Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996;14:397–440.

    Article  CAS  Google Scholar 

  • Garrido E, Delgado M, Martinez C, Gomariz RP, De la Fuente M. Pituitary adenylate cyclaseactivating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility. Neuropeptides 1996;30:583–95.

    Article  PubMed  CAS  Google Scholar 

  • Gaytan F, Martinez-Fuentes AJ, Gracia-Navarro F, Vaudry H, Aguilar E. Pituitary adenylate cyclase activating peptide (PACAP) immunolocalization in lymphoid tissue of rat. Cell Tissue Res 1994;276:233–37.

    Article  Google Scholar 

  • Gomariz RP, Lorenzo MJ, Cacicedo L, Vicente A, Zapata A. Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus. Brain Behav Immun 1990;4:151–61.

    Article  PubMed  CAS  Google Scholar 

  • Gomariz, RP, Garrido E, Leceta J, Martinez C, Abalo R, Delgado M. Gene expression of VIP receptor in rat lymphocytes. Biochem Biophys Res Commun 1994;203:1599–604.

    Article  PubMed  CAS  Google Scholar 

  • Gomariz RP, Leceta J, Martinez C, Abad C, Ganea D, Delgado M. Anti-inflammatory actions of VIP/PACAP. Role in endotoxemia. Ann NY Acad Sci 2000;921:284–88.

    Article  PubMed  CAS  Google Scholar 

  • Gomariz RP, Martinez C, Abad C, Leceta J, Delgado M. Immunology of VIP: a review and therapeutical perspectives. Cuff Pharm Des 2001;7:89–111.

    CAS  Google Scholar 

  • Guerrero JM, Prieto JC, Elorza FL, Ramirez R, Goberna R. Interaction of vasoactive intestinal peptide with human blood mononuclear cells. Mol Cell Endocrinol 1981;21:151–60.

    Article  PubMed  CAS  Google Scholar 

  • Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA. International Union of Pharmacology. XVII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclaseactivating polypeptide. Pharmacol Rev 1998;50:265–70.

    PubMed  CAS  Google Scholar 

  • Ichinose M, Asai M, Imai K, Sawada M. Enhancement of phagocytosis in mouse macrophages by pituitary adenylate cyclase-activating polypeptide (PACAP) and related peptides. Immunopharmacol 1995;30:217–24.

    Article  CAS  Google Scholar 

  • Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 1992;8:811–19.

    Article  PubMed  CAS  Google Scholar 

  • Ju ST, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BA, Marshak-Rothstein A. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995;373:444–48.

    Article  PubMed  CAS  Google Scholar 

  • Kaltreider HB, Ichkawa S, Byrd PK, Ingram DA, Kishiyama JL, Sreedharan SP, Warnock ML, Beck J, Goetzl EG. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am J Respir Cell Mol Biol 1997;16:133–44.

    PubMed  CAS  Google Scholar 

  • Karima R, Matsumoto S, Higashi H, Matsushima K. The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 1999;5:123–32.

    Article  PubMed  CAS  Google Scholar 

  • Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233–58.

    Article  PubMed  CAS  Google Scholar 

  • Martinez C, Delgado M, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide modulate endotoxin-induced IL6 production by murine peritoneal macrophages. J Leuk Biol 1998a;63:591–601.

    CAS  Google Scholar 

  • Martinez C, Delgado D, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP. VIP and PACAP enhance IL6 release and mRNA levels in resting peritoneal macrophages:in vitroandin vivostudies. J Neuroimmunol 1998b;85:155–67.

    Article  CAS  Google Scholar 

  • Martinez C, Delgado M, Abad C, Gomariz RP, Ganea D, Leceta J Regulation of VIP production and secretion by murine lymphocytes. J Neuroimmun 1999;93:126–28.

    Article  CAS  Google Scholar 

  • Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Thl /Th2 cytokine patterns and the arthriogenic response in collagen-induced arthritis. Eur J Immunol 1996;26:1511–20.

    Article  PubMed  CAS  Google Scholar 

  • O’Garra AO. Cytokines induce the development of functionally heterogenous T helper cell subsets. Immunity 1998;8:275–283.

    Article  PubMed  Google Scholar 

  • Ottaway CA, Greenberg G. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses. J Immunol 1984;132:417–23.

    PubMed  CAS  Google Scholar 

  • Pantaloni C, Brabet P, Bilanges B, Dumuis A, Houssami S, Spengler D, Bockaert J, Joumot L. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclaseactivating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem 1996;271:22146–51.

    Article  PubMed  CAS  Google Scholar 

  • Pozo D, Delgado M, Martinez C, Gomariz RP, Guerrero JM, Calvo JR. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages. Biochim Biophys Acta 1997;1359:250–62.

    Article  PubMed  CAS  Google Scholar 

  • Robberecht P, De Neef P, Gourlet P, Cauvin A, Coy DH, Christophe J. Pharmacological characterization of the novel heloderminNIP receptor present in human SUP-T1 lymphoma. Regul Pept 1989;26:117–26.

    Article  PubMed  CAS  Google Scholar 

  • Sakakibara H, Shima K, Said SI. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages. Am J Physiol 1994;267:L256–62.

    PubMed  CAS  Google Scholar 

  • Segura, JJ, Guerrero JM, Goberna R, Calvo JR. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages. Regul Pept 1991;33:133–43.

    Article  PubMed  CAS  Google Scholar 

  • Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, Ogawa T, Hamaoka T, Senoh H, Fujiwara H. Type II collagen-induced murine arthritis induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 1988;140:1477–84.

    PubMed  CAS  Google Scholar 

  • Smyth MJ. Fas ligand-mediated bystander lysis of syngeneic cells in response to an allogeneic stimulus. J Immunol 1997;158:5765–5772.

    PubMed  CAS  Google Scholar 

  • Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L. Differential signal transduction by five splice variants of the PACAP receptor gene. Nature 1993;365:170–75.

    Article  PubMed  CAS  Google Scholar 

  • Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligand in cells of the T cell lineage. J Immunol 1995;154: 3806–13.

    PubMed  CAS  Google Scholar 

  • Svoboda M, Tastenoy M, Ciccarelli E, Stievenart M, Cristophe J. Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor. Biochem Biophys Res Commun 1993;195:881–88.

    Article  PubMed  CAS  Google Scholar 

  • Tang H, Sun L, Xin Z, Ganea D. Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP. Ann. NY Acad. Sci. 1996;805:768–78.

    Article  PubMed  CAS  Google Scholar 

  • Taplits MS, Henkart PA, Hodes RJ. T helper cell cytoplasmic granules. Exocytosis in response to activation via the T cell receptor. J Immunol 1988;141:1–9.

    PubMed  CAS  Google Scholar 

  • Tatsuno I, Gottschall PE, Arimura A. Inhibition of mitogen-stimulated proliferation of murine splencytes by a novel neuropeptide, pituitary adenylate cyclase-activating polypeptide: a comparative study with vasoactive intestinal peptide. Endocrinology 1991;128:728–34.

    Article  PubMed  CAS  Google Scholar 

  • Vaudry D, Gonzalez BJ, Basille M, Jon L, Fournier A, Vaudry H. Pituitary adenylate cyclaseactivating polypeptide and its receptors: from structure to functions. Pharmacol Rev 2000;52:269–324.

    PubMed  CAS  Google Scholar 

  • Vincent J, Chamlou R. Sepsis trials. Curr Opin Anaesthesiol 1996;9:146–56.

    Article  Google Scholar 

  • Wiik P, Opstad PK, Boyum A. Binding of vasoactive intestinal polypeptide (VIP) by human blood monocytes: demonstration of specific binding sites. Regul Pept 1985;12:145–63.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Delgado, M., Leceta, J., Gomariz, R.P. (2003). Function of PACAP in the Immune System. In: Vaudry, H., Arimura, A. (eds) Pituitary Adenylate Cyclase-Activating Polypeptide. Endocrine Updates, vol 20. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0243-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0243-2_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4983-9

  • Online ISBN: 978-1-4615-0243-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics